Changping, Beijing, China In 1999 was created Lepu Medical, which is appeared as Corporate Investor. The venture was found in Asia in China. The main department of described Corporate Investor is located in the Changping.
The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Health Care, Biotechnology. Among the various public portfolio startups of the fund, we may underline 24tidy, Rgenix For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The fund was created by Zhongjie Pu.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Lepu Medical, startups are often financed by Sofinnova Partners, Sequoia Capital China, Paolo Rubatto. The meaningful sponsors for the fund in investment in the same round are Xiu2019an Jiaotong University Education Foundation, WuXi AppTec, Sofinnova Partners.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018. The usual things for fund are deals in the range of 50 - 100 millions dollars. When the investment is from Lepu Medical the average startup value is 500 millions - 1 billion dollars.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Shenda Endoscope | 20 Jul 2023 | Shenyang, Liaoning, China | |||
Guizhou Yizhiying Technology | 18 Jan 2023 | Jiangmen, Guangdong Province, China | |||
Lepu Bio | $139M | 02 Jul 2019 | Shanghai, China | ||
24tidy | $30M | 29 Nov 2018 | China, Shanghai | ||
Rgenix | $40M | 09 Oct 2018 | New York, United States | ||
Youjiali | $1M | 09 Oct 2015 | Songjiang, Songjiang District, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Shenda Endoscope | 20 Jul 2023 | Shenyang, Liaoning, China | |||
Guizhou Yizhiying Technology | 18 Jan 2023 | Jiangmen, Guangdong Province, China | |||
Lepu Bio | $139M | 02 Jul 2019 | Shanghai, China | ||
24tidy | $30M | 29 Nov 2018 | China, Shanghai | ||
Rgenix | $40M | 09 Oct 2018 | New York, United States | ||
Youjiali | $1M | 09 Oct 2015 | Songjiang, Songjiang District, China |
